XML 37 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Business Segments
9 Months Ended
Sep. 28, 2019
Segment Reporting [Abstract]  
Business Segments

10. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

 

 

 

Three Months Ended

 

 

 

Nine Months Ended

 

(in thousands)

 

September 28, 2019

 

 

September 29, 2018

 

 

 

September 28, 2019

 

 

September 29, 2018

 

G6

 

$

2,962

 

 

$

2,860

 

 

 

$

9,419

 

 

$

8,715

 

Retina

 

 

5,788

 

 

 

6,672

 

 

 

 

16,635

 

 

 

17,160

 

Other(1)

 

 

1,914

 

 

 

1,788

 

 

 

 

5,631

 

 

 

5,258

 

Total revenues

 

$

10,664

 

 

$

11,320

 

 

 

$

31,685

 

 

$

31,133

 

(1) Incudes service contract revenues of $437 and $388 and $1,041 and $985 recognized during the three and nine months ended September 28, 2019 and September 29, 2018, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

 

 

Revenue information shown by geographic region, based on the sales destination, is as follows:

 

 

 

Three Months Ended

 

 

 

Nine Months Ended

 

(in thousands)

 

September 28, 2019

 

 

September 29, 2018

 

 

 

September 28, 2019

 

 

September 29, 2018

 

United States

 

$

5,833

 

 

$

6,182

 

 

 

$

16,362

 

 

$

16,156

 

Europe

 

 

2,112

 

 

 

2,020

 

 

 

 

7,176

 

 

 

6,680

 

Rest of Americas

 

 

735

 

 

 

554

 

 

 

 

2,107

 

 

 

1,862

 

Asia/Pacific Rim

 

 

1,984

 

 

 

2,564

 

 

 

 

6,040

 

 

 

6,435

 

Total revenues

 

$

10,664

 

 

$

11,320

 

 

 

$

31,685

 

 

$

31,133

 

 

Revenues are attributed to countries based on location of end customers.

Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three and nine months ended September 28, 2019 and during the nine months ended September 29, 2018. Other than the United States, China accounted for more than 10% of the Company’s revenues during the three months ended September 29, 2018, representing 11%. The United States accounted for 54.7% and 54.6% of revenues for the three months ended September 28, 2019 and September 29, 2018, respectively. International sales accounted for 45.3% and 45.4% of revenues for the three months ended September 28, 2019 and September 29, 2018, respectively. For the nine months ended September 28, 2019 and September 29, 2018, the United States accounted for 51.6% and 51.9% of revenues, respectively. For the nine months ended September 28, 2019 and September 29, 2018, international sales accounted for 48.4% and 48.1% of revenues, respectively.